Los Angeles, Calif., February 15, 2018. Stability and consistency does the trick, especially in such turbulent times as we experienced last week. We all expected it, that long anticipated "correction", but when it actually arrives, it generates shock waves across all markets and stocks, emotions run amok and nerves are getting rattled. We are proud to report that even under those very unstable conditions, our SWI portfolio performed exceptionally well.

S&P Looses 11.3% - SWI Portfolio Gains 22%

Spread of 33.3% - Advantage SWI

This is a spread of 33.3%, which even for the most skeptical mind should confirm the SWI portfolio as a guide line to produce significant returns, even under the most difficult circumstances. Beyond this,we join the chorus of the top analysts in this country, who are assuring you that there is no reason for panic; this is not 2008. As a matter of fact, the current scenario should represent a buying opportunity for investors with a reasonable risk threshold. Still, you should not abandon your methodology and your typical due diligence process, or change your risk tolerance levels. Stick with your plan. Discipline will serve you well over the long term.

Or, follow our SWI portfolio, a portfolio that has a track record of stellar performance over nearly three years now. The good news is that we have increased the portfolio value by another 22% during the period to a total increase of 253% since inception, while the S&P has returned only 10.5% during the same period.

S&P Gain 10.5% - SWI Gains 253%

If you have followed us, you know that we have acquired positions for every stock in the SWI Portfolio and published this performance report since we opened the Portfolio, to make our performance stats completely transparent to our readers. Since inception nearly three years ago, our SWI Portfolio has consistently outperformed the major indices and most "Big-Firm" research portfolios; and the gap is widening. Our research team is always scouting the markets for new and exceptional opportunities to add to the portfolio.

We also encourage you to follow the companies that we are covering on our StockWatchIndex (SWI) website, in our "QuickPicks" reports and with our SWI Research Reports on SWI Research.com. The SWI website is updated at least once daily with the latest news on the companies we cover and important news highlighting market trends, mainly in BioTech, Technology and other disruptive developments and what we believe to be solid investment opportunities.

We will never publish sensational headlines about any of the stocks that we have acquired, companies that we represent, or have issued research reports on. We simply do the research, report the facts and let our performance track record speak for itself. Considering our solid 2-year track record, it should be worthwhile following our coverage and spreading the word. There is power in numbers. If you like our reports and our reporting transparency, we would appreciate if you recommended us to your friends.

If you want to follow all other companies that we cover with more in depth research reports, go to our research site at www.swiresearch.com/report-index to download the reports,

or visit www.stockwatchindex.com for up to date news on the covered companies.

Please feel free to re-distribute the reports to your friends and colleagues.

Rainer Poertner - Chief Analyst

StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party sources, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrants any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein, or any other of our publications. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has not been compensated for this report, has acquired positions of every stock in this report for its portfolio and reserves the right to buy or sell positions at its sole discretion. The included information is subject to change without notice. Please visit  www.swiresearch.com/#!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.